Related references
Note: Only part of the references are listed.Cancer Statistics, 2021
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Hepatocellular carcinoma
Josep M. Llovet et al.
NATURE REVIEWS DISEASE PRIMERS (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
The metabolism of cancer cells during metastasis
Gabriele Bergers et al.
NATURE REVIEWS CANCER (2021)
A Review of Curcumin and Its Derivatives as Anticancer Agents
Mhd Anas Tomeh et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Causes of death among cancer patients
N. G. Zaorsky et al.
ANNALS OF ONCOLOGY (2017)
In-silico and in-vitro anti-cancer potential of a curcumin analogue (1E, 6E)-1, 7-di (1H-indol-3-yl) hepta-1, 6-diene-3, 5-dione
Shamim Akhtar Sufi et al.
BIOMEDICINE & PHARMACOTHERAPY (2017)
Distinctive pharmacological differences between liver cancer cell lines HepG2 and Hep3B
Guo-Hua Qiu et al.
CYTOTECHNOLOGY (2015)
A novel synthetic oleanane triterpenoid suppresses adhesion, migration, and invasion of highly metastatic melanoma cells by modulating gelatinase signaling axis
Dona Sinha et al.
MOLECULAR CARCINOGENESIS (2015)
Curcumin Decreases Survival of Hep3B Liver and MCF-7 Breast Cancer Cells
Mareike Stroefer et al.
STRAHLENTHERAPIE UND ONKOLOGIE (2011)
CURCUMIN THERAPEUTIC PROMISES AND BIOAVAILABILITY IN COLORECTAL CANCER
A. Shehzad et al.
DRUGS OF TODAY (2010)
Curcumin inhibits Akt/mammalian target of rapamycin signaling through protein phosphatase-dependent mechanism
Siwang Yu et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Zymographic techniques for the analysis of matrix metalloproteinases and their inhibitors
PAM Snoek-van Beurden et al.
BIOTECHNIQUES (2005)
The prognostic molecular markers in hepatocellular carcinoma
LX Qin et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2002)